Takata I - Search Results

1

Daily low-dose cisplatin and concurrent thoracic irradiation for poor-risk patients with unresectable non-small-cell lung cancer.

Takata I, Ueoka H, Kiura K, Tabata M, Takigawa N, Katayama H, Takemoto M, Hiraki Y, Harada M, Tanimoto M. Takata I, et al. Acta Med Okayama. 2002 Oct;56(5):261-6. doi: 10.18926/AMO/31705. Acta Med Okayama. 2002. PMID: 12530510 Free article. Clinical Trial.

2

Atezolizumab-Induced Type 1 Diabetic Ketoacidosis in a Patient With Small Cell Lung Cancer and Pre-existing Type 2 Diabetes Mellitus.

Narumoto K, Oda N, Mitani R, Takata I. Narumoto K, et al. Among authors: takata i. Cureus. 2024 Mar 27;16(3):e57024. doi: 10.7759/cureus.57024. eCollection 2024 Mar. Cureus. 2024. PMID: 38681275 Free PMC article.

3

Establishment and characterization of a cell line, KaMi, from human lung large cell carcinoma.

Takata H, Yoshino T, Hoshida Y, Takata I, Akagi T. Takata H, et al. Among authors: takata i. Acta Med Okayama. 1992 Aug;46(4):257-64. doi: 10.18926/AMO/32620. Acta Med Okayama. 1992. PMID: 1279943 Free article.

4

Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation.

Takigawa N, Segawa Y, Okahara M, Maeda Y, Takata I, Kataoka M, Fujii M. Takigawa N, et al. Among authors: takata i. Lung Cancer. 1996 Aug;15(1):67-77. doi: 10.1016/0169-5002(96)00571-5. Lung Cancer. 1996. PMID: 8865124

5

Primary lung cancer associated with diffuse granulomatous lesions in the pulmonary parenchyma.

Segawa Y, Takigawa N, Okahara M, Maeda Y, Takata I, Fujii M, Mogami H, Mandai K, Kataoka M. Segawa Y, et al. Among authors: takata i. Intern Med. 1996 Sep;35(9):728-31. doi: 10.2169/internalmedicine.35.728. Intern Med. 1996. PMID: 8915701 Free article.

6

Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer.

Maeda Y, Segawa Y, Takigawa N, Takata I, Fujimoto N. Maeda Y, et al. Among authors: takata i. Intern Med. 1996 Oct;35(10):764-71. doi: 10.2169/internalmedicine.35.764. Intern Med. 1996. PMID: 8933183 Free article.

7

Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinicopathological evaluation.

Segawa Y, Takigawa N, Mandai K, Maeda Y, Takata I, Fujimoto N, Jinno K. Segawa Y, et al. Among authors: takata i. Lung Cancer. 1997 Mar;16(2-3):229-38. doi: 10.1016/s0169-5002(97)82785-7. Lung Cancer. 1997. PMID: 9152954

8

Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients.

Takigawa N, Segawa Y, Maeda Y, Takata I, Fujimoto N. Takigawa N, et al. Among authors: takata i. Lung Cancer. 1997 Jul;17(2-3):211-8. doi: 10.1016/s0169-5002(97)00651-x. Lung Cancer. 1997. PMID: 9237156

9

Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer.

Segawa Y, Takigawa N, Kataoka M, Takata I, Fujimoto N, Ueoka H. Segawa Y, et al. Among authors: takata i. Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):91-8. doi: 10.1016/s0360-3016(97)00297-6. Int J Radiat Oncol Biol Phys. 1997. PMID: 9300744

10

Serum CD44 levels in patients with non-small cell lung cancer and their relationship with clinicopathological features.

Takigawa N, Segawa Y, Mandai K, Takata I, Fujimoto N. Takigawa N, et al. Among authors: takata i. Lung Cancer. 1997 Oct;18(2):147-57. doi: 10.1016/s0169-5002(97)00060-3. Lung Cancer. 1997. PMID: 9316006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters